Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Inflammatory Bowel Disease III: Crohn's Disease01:25

Inflammatory Bowel Disease III: Crohn's Disease

Crohn’s disease is a chronic, relapsing form of inflammatory bowel disease characterized by segmental, transmural inflammation that can affect any part of the gastrointestinal tract. Its pathogenesis arises from a combination of genetic susceptibility, environmental exposures, epithelial barrier dysfunction, and immune dysregulation. Together, these factors lead to an exaggerated immune response against components of the gut microbiome.Genetic and Environmental InfluencesMultiple genetic...
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Diverticular Disease of the Colon01:27

Diverticular Disease of the Colon

Diverticular disease involves the formation of diverticula—small sac-like outpouchings of the colonic wall—and their complications. It most commonly affects the sigmoid colon due to higher intraluminal pressure and structural vulnerability. It results from structural weakness and increased pressure in the colon, producing pseudodiverticula that may remain silent or progress to inflammation and serious complications.Structure of DiverticulaIn diverticulosis, these outpouchings are...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Heparanase inhibition prevents glycocalyx damage and albuminuria in experimental minimal change disease.

Clinical and translational medicine·2026
Same author

SARS-CoV-2 Omicron infection reveals imprinted antibody responses in the absence of vaccination.

iScience·2026
Same author

Endothelial-erythrocyte glycocalyx exchange enables liquid biopsies of endothelial function.

Nature communications·2026
Same author

Whole-genome sequencing to investigate the prevalence and transmission of multidrug-resistant Gram-negative pathogens in an adult intensive care unit in the UK.

Microbial genomics·2026
Same author

Use of TaqMan array card to investigate bacterial isolates in diabetic foot ulcers.

Journal of medical microbiology·2026
Same author

Sero-genomic evidence for occult mpox exposure in healthy Nigerian adults.

Nature communications·2026

Related Experiment Video

Updated: Jun 1, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Clostridium difficile in children: colonisation and disease.

David A Enoch1, Matthew J Butler, Sumita Pai

  • 1Clinical Microbiology and Public Health Laboratory, Peterborough and Stamford NHS Foundation Trust, Peterborough City Hospital, Bretton Gate, Peterborough, PE3 9GZ, UK.

The Journal of Infection
|June 14, 2011
PubMed
Summary

Clostridium difficile (C. diff) causes hospital-acquired diarrhea in adults, but its role in children is unclear. This article reviews childhood C. diff infection, covering risk factors, spread, and treatment strategies.

More Related Videos

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Related Experiment Videos

Last Updated: Jun 1, 2026

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291
06:51

Cefoperazone-treated Mouse Model of Clinically-relevant Clostridium difficile Strain R20291

Published on: December 10, 2016

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection
07:06

Fecal Microbiota Transplantation via Colonoscopy for Recurrent C. difficile Infection

Published on: December 8, 2014

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment
11:13

Culturing and Maintaining Clostridium difficile in an Anaerobic Environment

Published on: September 14, 2013

Area of Science:

  • Pediatric Infectious Diseases
  • Microbiology
  • Hospital Epidemiology

Background:

  • Clostridium difficile is a leading cause of nosocomial diarrhea in adults, linked to severe illness and death.
  • The clinical impact and significance of C. difficile infections (CDI) in pediatric populations remain less understood compared to adults.
  • Understanding childhood CDI is crucial for effective public health strategies and patient management.

Purpose of the Study:

  • To elucidate the clinical significance of Clostridium difficile in children.
  • To discuss the epidemiology, risk factors, and management of C. difficile in pediatric patients.
  • To differentiate between colonization and active infection in childhood CDI cases.

Main Methods:

  • Review of existing literature on Clostridium difficile in pediatric populations.
  • Analysis of epidemiological data and risk factors associated with childhood CDI.
  • Discussion of diagnostic approaches and treatment guidelines for pediatric C. difficile.

Main Results:

  • Clostridium difficile is identified as a significant pathogen in pediatric hospital-acquired diarrhea.
  • Specific risk factors in children include antibiotic exposure, prolonged hospitalization, and healthcare settings.
  • The distinction between asymptomatic colonization and symptomatic infection is critical for appropriate management.

Conclusions:

  • Clostridium difficile poses a notable threat in pediatric healthcare settings, necessitating careful consideration.
  • Early recognition of risk factors and prompt management are key to improving outcomes for children with CDI.
  • Further research is warranted to fully understand the long-term implications and specific treatment nuances in pediatric populations.